▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #990 by analyst upside · 2026-09-29
CRMD
CorMedix Inc.
Healthcare · Market Cap $615M · P/E 3.6x
ANALYST PRICE TARGET
+94.3%
implied upside to consensus target
Current Price $7.89
Consensus Target $15.33
Bull Target $19.0
Bear Target $13.0
Analysts Covering 6
ANALYST CONSENSUS - STRONG BUY
Strong Buy
3
Buy
3
Hold
0
Sell
0
52-Week Low $6.13
52-Week High $13.02
YTD Return -35.1%
FUNDAMENTALS
Market Cap $615M
P/E Ratio (TTM) 3.6x
Forward P/E 22.5x
EPS (TTM) $2.21
PEG Ratio 5.61
Dividend Yield N/A
Revenue (TTM) $462M
Profit Margin 40.5%
52-WEEK RANGE
52-Week Low $6.13
52-Week High $13.02
Current Price $7.89
Bear Target $13.0
Bull Target $19.0
● Now $7.89 ● Target $15.33
TRADING DATA
Avg Volume 1.1M
YTD Return -35.1%
Analyst Count 6
Consensus Strong Buy
Upside to Target +94.3%
Last Updated 2026-09-29

ANALYST SUMMARY

CorMedix Inc. (CRMD) is currently trading at $7.89 with a Wall Street consensus price target of $15.33, implying potential upside of 94.3% over the next 12 months. 6 analysts currently cover CRMD, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $19.0, while the most cautious has a target of $13.0.

CRMD operates in the Healthcare sector with a market capitalisation of $615M. The stock is down 35.1% year-to-date and is currently trading near the lower end of its 52-week range of $6.13 – $13.02.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

VREX +2.4%
Varex Imaging Corporation
$784M · P/E 34.8x · Hold
INVA +64.9%
Innoviva, Inc.
$2B · P/E 4.8x · Buy
HSTM +18.4%
HealthStream, Inc.
$892M · P/E 40.5x · Buy
CYH +9.2%
Community Health Systems, Inc.
$408M · P/E 1.6x · Hold
UFPT +18.6%
UFP Technologies, Inc.
$2B · P/E 31.9x · Underperform

RECENT ANALYST CALLS

Upgrade/downgrade history for CRMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Oppenheimer ● Initiated
Outperform 2026-09-23 14% win rate (7 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-08-14 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-07 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-04-28 Building track record
Citizens reit
Market Outperform → Market Outperform 2026-04-28 Building track record
Leerink Partners - Reiterated
Outperform → Outperform 2026-04-28 29% win rate (7 calls)
Needham - Reiterated
Buy → Buy 2026-04-27 20% win rate (5 calls)
D. Boral Capital - Reiterated
Buy → Buy 2026-04-27 32% win rate (25 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
57
out of 100
Coverage depth
15/30
Consensus clarity
15/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →